CS Marketing
Group, LLC brings innovative technologies to the marketplace. Our goal
is to
provide the medical industry with a fresh, new approach on how to
diagnose, track, and ultimately prevent heart dysfunctions.
CS Marketing Group, LLC has exclusive USA marketing rights for the CS-100 from Trigon
Medical Devices Inc.
Cardiovascular
disease is not only the number one cause of
death in the world today, but also the number one cause of sudden
death.
Over one million deaths in the United States
and over seven million worldwide
occur as a result of this disease. Approximately 23% of heart
attacks go
undetected every year. Undetected heart attacks are a sign of
cardiovascular disease which, in turn, can lead to an irreversible
debilitating
condition.
Over the years,
approximately $30 billion in payments have
been made to Medicare beneficiaries for hospital expenses as a result
of
cardiovascular disease. The CS-100 is based on a patented FCG
diagnostic
model which is more accurate than most contemporary diagnostics and
proves to
be a very effective screening tool to detect heart diseases in their
earliest
stages.
|